Abstract
Several molecules have been evaluated with regard to antiviral action against SARS-CoV-2 and in the treatment of complications from Covid-19, but to date, there are no drugs of significant efficacy. SARS-CoV-2 infection is still a concern because Covid-19 occasionally leads to severe clinical outcomes. Research aimed at exploring candidate molecules for the development of a drug is of ext…